Innovative Cellular Therapeutics Holdings Ltd 4

What Happened Innovative Cellular Therapeutics Holdings Ltd, listed as a 10% owner of Lyell Immunopharma (LYEL), reported a sale of 10 shares on July 16, 2026. The shares were sold at $13.73 each for a total proceeds of $137. This was a sale (routine disposition) rather than a purchase.

Key Details

• Transaction date: 2026-07-16; Filing date: 2026-07-17.
• Price and amount: 10 shares at $13.73 per share; total value $137.
• Shares owned after transaction: Footnote F1 shows 2,857,500 shares beneficially owned immediately prior to the trade; after selling 10 shares the holder beneficially owns 2,857,490 shares.
• Transaction type: Sale (open market or private sale as reported).
• No late-filing flag is indicated in the record provided.

Context This is an institutional 10% owner, not an individual executive — such holders are often investment entities and small disposals (10 shares, ~0.00035% of the prior stake) are typically routine and not a strong signal of management sentiment. The dollar amount is negligible relative to the holder's total position.